Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc. financial statements

Virpax Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 0EODHD
Net income−USD 12.07MEODHD
Cash and equivalentsUSD 1.51MEODHD

Virpax Pharmaceuticals, Inc. financials on 6ix · Virpax Pharmaceuticals, Inc. on 6ix